News
MEDIA INQUIRIES
Please contact Colleen O’Malley, Sr. Director, Marketing & Communications, ABTA at 773-577-8750.
ABTA Press Releases
New Statistical Report Reveals Primary Brain and Central Nervous System Tumors as Second Most Common Cancer Type in Adolescents and Young Adults
CHICAGO (May 7, 2024)—Today, the American Brain Tumor Association (ABTA), in partnership with the National Institutes of Health’s National Cancer Institute (NCI) Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) program and the Central Brain Tumor Registry of the United States (CBTRUS), unveiled a new report shedding light on the prevalence of primary brain and other central nervous system (CNS) tumors among adolescents and young adults (AYAs) between the ages of 15 and 39.
ABTA President and CEO Ralph A. DeVitto Announces Retirement
Chicago, IL (May 6, 2024)—The American Brain Tumor Association (ABTA) announced that President and CEO Ralph A. DeVitto has informed the Board of Directors of his intention to retire from ABTA in January 2025, after leading the organization for nearly seven years.
American Brain Tumor Association Announces New Board of Directors Officers and Members
Meet the ABTA’s newest Board Members, Laura Aguilar, MD, PhD, and Charles (Chad) Schafer, JD.
ABTA Announces $1.3 Million in New Funding to Accelerate Adult and Pediatric Brain Tumor Research
The American Brain Tumor Association (ABTA) today announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages. Dedicated to advancing the field of neuro-oncology and accelerating the discovery of life-saving treatments, the ABTA is proud to have invested more than $35 million, to approximately 700 researchers to support 800 projects, to date.
